GenomeDx's Decipher Prostate Cancer Test is Significant Predictor of …

GenomeDx's Decipher Prostate Cancer Test is Significant Predictor of …

Also highlighted today, Ashley Ross, M.D., of The Brady Urologic Institute at Johns Hopkins School of Medicine, presented data from a study titled "Tissue Based Genomics Augment Post-Prostatectomy Risk Stratification in a Natural History Cohort". The

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Write a comment

*